We present a case of pleural effusion with encapsulation that was observed in the right thorax of a patient. PCR analysis of the patient's pleural effusion showed positivity for Mycobacterium tuberculosis. After six months, his chest CT showed the development of niveau and pulmonary consolidation. We definitively diagnosed him as having chronic pulmonary tuberculosis with tuberculous empyema drainage. At the time of his hospital admission, his serum carcinoembryonic antigen (CEA) level was elevated. After we started treatment using antituberculosis drugs, the infiltration shadow in his lung fields disappeared, and the serum CEA level decreased. The results suggest that the serum CEA level reflects the extent of the development of pulmonary tuberculosis lesions.
Introduction
The serum CEA level is increased in not only patients who have malignant tumors but also in those who smoke and have benign diseases such as pulmonary tuberculosis and chronic bronchitis. It has been reported that the positivity rate for an increase in the serum CEA level in patients with pulmonary tuberculosis is 16.9%; however, the increase in the serum CEA level is usually negligible, and serum CEA does not reach a level higher than 10 ng/ml (1) . Here, we report the case of a patient with tuberculous empyema formation due to pulmonary tuberculosis characterized by a marked increase in serum CEA level and the drainage of his tuberculous empyema, as determined when he was hospitalized for stomach cancer surgery. The infiltration shadow in his lung fields improved and his serum CEA level decreased after the start of treatment with antituberculosis drugs.
Case Report
We present the case of a 68-year-old man with a history of right tuberculous pleurisy in his right lung at the age of 20. In May 2003, he was diagnosed as having an encapsulated pleural effusion in his right thorax on the basis of findings of chest CT carried out when he was hospitalized for stomach cancer (Borrmann type II) surgery. His pleural effusion, which did not drain, was negative for M. tuberculosis. However, PCR analysis showed positivity for M. tuberculosis; thus, we diagnosed him as having tuberculous pleurisy. However, he refused to undergo treatment and left the hospital untreated. After six months, his chest radiographs showed the development of niveau in his right thorax and an exacerbation of the infiltration shadow in his lung fields (Fig. 1) . Therefore, the patient was admitted to our hospital. His chest CT carried out upon admission showed the development of niveau in his right pleural cavity and pulmonary consolidation, as shown in his air bronchogram, in all the lobes of his right lung ( Fig. 2-A) . His blood biochemical findings suggested a slightly enhanced inflammatory response (Table 1 ). In addition, his serum CEA level increased to 17.8 ng/ml. Both his initial sputum smear and PCR analysis showed negativity for M. tuberculosis. However, his sputum smear after three weeks was positive for M. tubercu- s h o wi n g a d e c r e a s e i n t h e v o l u me o f h i s p l e u r a l e f f u s i o n . losis. Thus, we diagnosed him as having chronic pulmonary tuberculosis with tuberculous empyema drainage. Before and after his stomach cancer surgery, his serum CEA level increased to 2-4 ng/ml. His serum CEA level further increased to 17.8 ng/ml after the drainage of his tuberculous empyema (Table 2) . Because his sputum culture was positive for M. tuberculosis, we started treating him with rifampicin (RFP), isoniazid (INH), ethambutol hydrochloride (EB), and pyrazinamide (PZA). About five months after the start of the treatment, the pulmonary consolidation of his right lung field improved markedly and he had a decrease in pleural effusion volume on chest radiographs and CT images (Fig. 2-B) .
F i g u r e 1 . Ch e s t r a d i o g r a p h o n a d mi s s i o n , s h o wi n g t h e n i v e a u i n h i s r i g h t t h o r a x a n d a n e x a c e r b a t i o n o f t h e i n f i l t r a t i v e s h a d o w o f h i s l u n g f i e l d .

F i g u r e 2 . ( A) Ch e s t CT o n a d mi s s i o n , s h o wi n g t h e n i v e a u i n h i s r i g h t p l e u r a l c a v i t y a n d p u l mo n a r y c o n s o l i d a t i o n i n h i s a i r b r o n c h o g r a m i n a l l t h e l o b e s o f h i s r i g h t l u n g . ( B ) Ch e s t CT a f t e r t r e a t me n t , s h o wi n g t h e p u l mo n a r y c o n s o l i d a t i o n o f h i s r i g h t l u n g f i e l d i mp r o v e d ma r k e d l y a n d
We treated him with antituberculosis drugs for nine months. We did not observe recurrence of pulmonary tuberculosis or a reincrease in his serum CEA level after the completion of this treatment.
Discussion
There are several reports on the measurement of tumor serum markers in patients with pulmonary tuberculosis. The glycoprotein common in gastrointestinal carcinoma and the fetal digestive organ was termed CEA by Gold and Freedman in 1965 (2) . Later, serum CEA was used as a marker of gastrointestinal carcinoma (3) . The measurement of serum CEA level is presently used as an additional method to confirm the diagnosis of various diseases. The serum CEA level is increased not only in patients who have malignant tumors but also in those who smoke (4) and have benign diseases such as pulmonary tuberculosis and chronic bronchitis (5). Serum CEA produced in bronchi and alveoli is typically drained into the airway. However, because the barrier between the airway and the blood vessels is considered to be destroyed in respiratory diseases, CEA accumulates at high levels in the blood. It is considered that the serum CEA level increases by a similar mechanism in tuberculosis. To the best of our knowledge, there has been no detailed report on the mechanism underlying the increase in CEA level in tuberculosis.
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ble, and serum CEA does not reach a level higher than 10 ng/ml. In the present patient, tuberculous empyema developed as a result of chronic pulmonary tuberculosis accompanied by an increase in serum CEA level during the drainage of his empyema. Our patient's serum CEA level was very high (17.8 ng/ml) ; patients with serum CEA levels higher than 10 ng/ml are extremely rare. His stomach cancer did not recur after the surgery, as shown by various examinations. We confirmed the positivity for M. tuberculosis in his sputum culture. An improvement of the infiltration shadow in his lung fields and a decrease in the volume of his pleural effusion were achieved after we started administering a combination of antituberculosis drugs, namely, RFP, INH, EB and PZA. His serum CEA level reached the maximum immediately after empyema drainage and began to decrease after we started the therapy using the combination of antituberculosis drugs. Subsequently, his serum CEA level further decreased with the improvement of his chest CT findings. Therefore, it is considered that serum CEA level can be used as a marker of the extent of the development of lesions in pulmonary tuberculosis. When we find an abnormal chest shadow together with an increased serum CEA level, as well as the presence of a malignant tumor, it is necessary to include pulmonary tuberculosis in the differential diagnosis. It is also suggested that changes in the serum CEA level are an important indicator of the clinical progression of pulmonary tuberculosis.
